copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Shionogi Co. , Ltd. At SHIONOGI, we have passionate colleagues who embody the spirit that has been passed down for over 140 years We are excited to share our story of working for patients around the world, society, and our irreplaceable planet
Pipeline | Innovation | Shionogi Inc. - A Discovery-Based . . . Shionogi has a long history of small molecule drug discovery Our current pipeline includes projects across several therapeutic areas, including infectious disease We are advancing clinical programs for infectious disease, rare disease, acute ischemic stroke and oncology
About Us | Shionogi Inc. Shionogi Inc is the U S subsidiary of Shionogi Co , Ltd , a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan In the U S , Shionogi Inc leverages our science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas…
Careersand Culture | Shionogi Inc. At Shionogi, we are driven to make an impact for patients and bring value to the communities we serve In pursuit of delivering medicines to address unmet medical needs, we challenge the status quo, invite passionate debate, and work together as one team
Products: Bringing Innovative Medicines to Patients - Shionogi To request medical information, report an adverse event (medication side effect) or report a product complaint for a Shionogi Inc product, please visit the Medical Information page or call 1 800 849 9707
About Shionogi | Shionogi Co. , Ltd. Shionogi is enhancing our strengths as a drug discovery-based pharmaceutical company to create innovative products and services and to deliver value in collaboration with a diverse array of partners
News | Shionogi Co. , Ltd. Shionogi Receives Award Through BARDA's Rapid Response Partnership Vehicle to Advance Long-Acting Formulation of S-892216, an Antiviral for COVID-19 Pre-Exposure Prophylaxis in At-Risk Populations
Contact | Shionogi Inc. - A Discovery-Based Pharmaceutical Company To request medical information, report an adverse event (medication side effect) or report a product complaint for a Shionogi Inc product, please visit the Medical Information page or call 1 800 849 9707